Analysts Set National Health Investors, Inc. (NYSE:NHI) Target Price at $75.33

Shares of National Health Investors, Inc. (NYSE:NHI) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $75.33.

Several equities research analysts have weighed in on NHI shares. Bank of America started coverage on shares of National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price for the company. Truist Financial dropped their target price on National Health Investors from $78.00 to $72.00 and set a “hold” rating on the stock in a research note on Monday, December 23rd. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and raised their price target for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Finally, StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th.

National Health Investors Trading Down 2.2 %

Shares of NYSE:NHI opened at $66.22 on Tuesday. The company has a market capitalization of $3.01 billion, a PE ratio of 22.76, a P/E/G ratio of 4.86 and a beta of 1.06. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 12-month low of $51.59 and a 12-month high of $86.13. The business’s fifty day simple moving average is $73.62 and its 200-day simple moving average is $75.81.

National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. During the same quarter last year, the firm earned $1.08 EPS. National Health Investors’s revenue for the quarter was up 1.7% on a year-over-year basis. As a group, equities research analysts predict that National Health Investors will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be given a $0.90 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a yield of 5.44%. National Health Investors’s dividend payout ratio is currently 123.71%.

Hedge Funds Weigh In On National Health Investors

A number of institutional investors have recently bought and sold shares of the business. Jane Street Group LLC increased its stake in shares of National Health Investors by 68.3% in the third quarter. Jane Street Group LLC now owns 60,099 shares of the real estate investment trust’s stock worth $5,052,000 after acquiring an additional 24,380 shares during the period. Strategic Financial Concepts LLC acquired a new stake in National Health Investors during the 2nd quarter worth about $28,000. Thrivent Financial for Lutherans purchased a new position in shares of National Health Investors during the 3rd quarter valued at about $2,426,000. Point72 Asset Management L.P. purchased a new stake in shares of National Health Investors in the third quarter worth about $688,000. Finally, Acadian Asset Management LLC purchased a new stake in shares of National Health Investors in the second quarter worth about $457,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.